speb/financial-data huggingface dataset:
CHRD balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 292405000.00
CHRD cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: -11672000.00
CHRD cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -215153000.00
CHRD balance_sheet (quarterly, 2025-03-31) — Net Debt: 763070000.00
CHRD income_statement (quarterly, 2025-03-31) — Net Income: 219837000.00
CHRD income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 218608000.00
CHRD income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 219837000.00
CHRD income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 219837000.00
CHRD income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 219837000.00
CHRD cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 219837000.00
CHRD income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 219837000.00
CHRD income_statement (quarterly, 2025-03-31) — Net Interest Income: -15818000.00
CHRD cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 972000.00
CHRD cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -36847000.00
CHRD cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -36847000.00
CHRD income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -15818000.00
CHRD cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -27355000.00
CHRD cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: 25000000.00
CHRD balance_sheet (quarterly, 2025-03-31) — Net PPE: 10742893000.00
CHRD balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 8088048000.00
CHRD balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 1526207000.00
CHRD balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 1526207000.00
CHRD income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 676888000.00
CHRD income_statement (quarterly, 2025-03-31) — Normalized Income: 233536578.10
CHRD cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 656893000.00
CHRD cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 23159000.00
CHRD income_statement (quarterly, 2025-03-31) — Operating Income: 332480000.00
CHRD income_statement (quarterly, 2025-03-31) — Operating Revenue: 1215047000.00
CHRD balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 58197374.00
CHRD balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 82146000.00
CHRD balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 109947000.00
CHRD income_statement (quarterly, 2025-03-31) — Other Gand A: 38377000.00
CHRD income_statement (quarterly, 2025-03-31) — Other Income Expense: -23660000.00
CHRD cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -9762000.00
CHRD balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 47969000.00
CHRD balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 5451000.00
CHRD income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -501000.00
CHRD income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 1983000.00
CHRD balance_sheet (quarterly, 2025-03-31) — Other Payable: 740750000.00
CHRD balance_sheet (quarterly, 2025-03-31) — Other Properties: 87117000.00
CHRD income_statement (quarterly, 2025-03-31) — Other Special Charges: 3494000.00
CHRD income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 1229000.00
CHRD balance_sheet (quarterly, 2025-03-31) — Payables: 885351000.00
CHRD balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 1518888000.00
CHRD balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 24453000.00
CHRD income_statement (quarterly, 2025-03-31) — Pretax Income: 293002000.00
CHRD cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 0.00
CHRD cash_flow (quarterly, 2025-03-31) — Purchase Of Business: -17876000.00
CHRD balance_sheet (quarterly, 2025-03-31) — Raw Materials: 103798000.00
CHRD balance_sheet (quarterly, 2025-03-31) — Receivables: 1318383000.00
CHRD balance_sheet (quarterly, 2025-03-31) — Receivables Adjustments Allowances: -12083000.00
CHRD income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 842207000.00
CHRD income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 349809000.00
CHRD cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -1846847000.00
CHRD cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -215153000.00
CHRD balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 2444063000.00
CHRD cash_flow (quarterly, 2025-03-31) — Sale Of Business: 6204000.00
CHRD cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 972000.00
CHRD income_statement (quarterly, 2025-03-31) — Selling General And Administration: 38377000.00
CHRD balance_sheet (quarterly, 2025-03-31) — Share Issued: 67088756.00
CHRD income_statement (quarterly, 2025-03-31) — Special Income Charges: 2022000.00
CHRD cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 6876000.00
CHRD balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 8618664000.00
CHRD balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 8088048000.00
CHRD income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -4559421.90
CHRD income_statement (quarterly, 2025-03-31) — Tax Provision: 73165000.00
CHRD income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.25
CHRD balance_sheet (quarterly, 2025-03-31) — Total Assets: 13058608000.00
CHRD balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 9417488000.00
CHRD balance_sheet (quarterly, 2025-03-31) — Total Debt: 968011000.00
CHRD balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 8618664000.00
CHRD income_statement (quarterly, 2025-03-31) — Total Expenses: 882567000.00
CHRD balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 4439944000.00
CHRD balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 11461320000.00
CHRD balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 2636745000.00
CHRD income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 337996000.00
CHRD balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 47859000.00
CHRD income_statement (quarterly, 2025-03-31) — Total Unusual Items: -18259000.00
CHRD income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -18259000.00
CHRD balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 8891382.00
CHRD balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 1154684000.00
CHRD balance_sheet (quarterly, 2025-03-31) — Working Capital: -205911000.00
CHRD income_statement (quarterly, 2025-06-30) — +Operating Expense: 32540000.00
CHRD income_statement (quarterly, 2025-06-30) — +Total Revenue: 1180560000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 74043000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 1010342000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -2851535000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 7327295000.00
CHRD cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 539317000.00
CHRD income_statement (quarterly, 2025-06-30) — Average Dilution Earnings: -3604000.00
CHRD income_statement (quarterly, 2025-06-30) — Basic Average Shares: 57786000.00
CHRD income_statement (quarterly, 2025-06-30) — Basic EPS: -6.71
CHRD cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 35754000.00
CHRD cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -395475000.00
CHRD cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: -395475000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 171787000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Capital Stock: 675000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 40487000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 40487000.00
CHRD cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -82382000.00
CHRD cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -29565000.00
CHRD cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -385512000.00
CHRD cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 419810000.00
CHRD cash_flow (quarterly, 2025-06-30) — Change In Inventory: 3761000.00
CHRD cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -3208000.00
CHRD cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -80384000.00
CHRD cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 258000.00
CHRD cash_flow (quarterly, 2025-06-30) — Change In Receivables: 29848000.00
CHRD cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -49725000.00
CHRD cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 29848000.00
CHRD cash_flow (quarterly, 2025-06-30) — Changes In Cash: 4733000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Common Stock: 675000.00
CHRD cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -82382000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 8096224000.00
CHRD cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -58861000.00
CHRD income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 1008773000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 625188000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Current Assets: 1523685000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 163553000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 163553000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 2715000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 1576635000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Current Provisions: 19848000.00
CHRD cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 19285000.00
CHRD cash_flow (quarterly, 2025-06-30) — Deferred Tax: 19285000.00
CHRD cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 376997000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Derivative Product Liabilities: 2500000.00
CHRD income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 57786000.00
CHRD income_statement (quarterly, 2025-06-30) — Diluted EPS: -6.77
CHRD income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -391197000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Dividends Payable: 0.00
CHRD cash_flow (quarterly, 2025-06-30) — Dividends Received Cfi: 4443000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Duefrom Related Parties Current: 282586000.00
CHRD income_statement (quarterly, 2025-06-30) — EBIT: -316901000.00
CHRD income_statement (quarterly, 2025-06-30) — EBITDA: 60096000.00
CHRD income_statement (quarterly, 2025-06-30) — Earnings From Equity Interest: -962000.00
CHRD cash_flow (quarterly, 2025-06-30) — Earnings Losses From Equity Investments: 962000.00
CHRD cash_flow (quarterly, 2025-06-30) — End Cash Position: 40487000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Financial Assets: 7962000.00
CHRD cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -29565000.00
CHRD cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 24335000.00
CHRD cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: -82231000.00
CHRD income_statement (quarterly, 2025-06-30) — Gain On Sale Of Ppe: -522000.00
CHRD income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 82231000.00
CHRD income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 32540000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Goodwill: 0.00
CHRD balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 0.00
CHRD balance_sheet (quarterly, 2025-06-30) — Gross PPE: 13685865000.00
CHRD income_statement (quarterly, 2025-06-30) — Gross Profit: 171787000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Hedging Assets Current: 82069000.00
CHRD income_statement (quarterly, 2025-06-30) — Impairment Of Capital Assets: 539300000.00
CHRD income_statement (quarterly, 2025-06-30) — Interest Expense: 18788000.00
CHRD income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 18788000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Interest Payable: 18586000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Inventory: 102031000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Invested Capital: 9015125000.00
CHRD cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -385512000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 131603000.00
CHRD cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 1375000000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 8234000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 918901000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 927135000.00
CHRD cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 1375000000.00
CHRD cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -1255441000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 131603000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Long Term Provisions: 392742000.00
CHRD cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: -7598000.00
CHRD cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -58861000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Net Debt: 878414000.00
CHRD income_statement (quarterly, 2025-06-30) — Net Income: -389905000.00
CHRD income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -387593000.00
CHRD income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -389905000.00
CHRD income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -389905000.00
CHRD income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -389905000.00
CHRD cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -389905000.00
CHRD income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -389905000.00
CHRD income_statement (quarterly, 2025-06-30) — Net Interest Income: -18788000.00
CHRD cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 13118000.00
CHRD cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 119559000.00
CHRD cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 119559000.00
CHRD income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -18788000.00
CHRD cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -7881000.00
CHRD cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: 0.00
CHRD balance_sheet (quarterly, 2025-06-30) — Net PPE: 10834330000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 8096224000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 1545492000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 1545492000.00
CHRD income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 520327000.00
CHRD income_statement (quarterly, 2025-06-30) — Normalized Income: -26322510.00
CHRD cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 419810000.00
CHRD cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -80746000.00
CHRD income_statement (quarterly, 2025-06-30) — Operating Income: 139247000.00
CHRD income_statement (quarterly, 2025-06-30) — Operating Revenue: 1180560000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 57649136.00
CHRD balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 2168000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 9780000.00
CHRD income_statement (quarterly, 2025-06-30) — Other Gand A: 32540000.00
CHRD income_statement (quarterly, 2025-06-30) — Other Income Expense: -456148000.00
CHRD cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -1535000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 49016000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 5868000.00
CHRD income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 5045000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Other Payable: 632109000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Other Properties: 83784000.00
CHRD income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: -2312000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Payables: 755551000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 1380739000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 17874000.00
CHRD income_statement (quarterly, 2025-06-30) — Pretax Income: -335689000.00
CHRD cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 0.00
CHRD cash_flow (quarterly, 2025-06-30) — Purchase Of Business: -8315000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Raw Materials: 102031000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Receivables: 1279056000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Receivables Adjustments Allowances: -13872000.00
CHRD income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 1008773000.00
CHRD income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 376997000.00
CHRD cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -1255441000.00
CHRD cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -58861000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 1978425000.00
CHRD cash_flow (quarterly, 2025-06-30) — Sale Of Business: 717000.00
CHRD cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 13118000.00
CHRD income_statement (quarterly, 2025-06-30) — Selling General And Administration: 32540000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Share Issued: 67146139.00
CHRD income_statement (quarterly, 2025-06-30) — Special Income Charges: -542462000.00
CHRD cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 6121000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 8096224000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 8096224000.00
CHRD income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -96648510.00
CHRD income_statement (quarterly, 2025-06-30) — Tax Provision: 54216000.00
CHRD income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
CHRD balance_sheet (quarterly, 2025-06-30) — Total Assets: 12546596000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 9015125000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Total Debt: 1090688000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 8096224000.00
CHRD income_statement (quarterly, 2025-06-30) — Total Expenses: 1041313000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 4450372000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 11022911000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 2873737000.00
CHRD income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -403215000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 49399000.00
CHRD income_statement (quarterly, 2025-06-30) — Total Unusual Items: -460231000.00
CHRD income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -460231000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 9497003.00
CHRD balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 1210171000.00
CHRD balance_sheet (quarterly, 2025-06-30) — Working Capital: -52950000.00
CHRD income_statement (quarterly, 2025-06-30) — Write Off: 2640000.00
CHRD income_statement (quarterly, 2025-09-30) — +Operating Expense: 23895000.00
CHRD income_statement (quarterly, 2025-09-30) — +Total Revenue: 1312081000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 61627000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 945608000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -3215842000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 7333496000.00
CHRD cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 5000.00
CHRD income_statement (quarterly, 2025-09-30) — Average Dilution Earnings: 0.00
CHRD income_statement (quarterly, 2025-09-30) — Basic Average Shares: 57157000.00
CHRD income_statement (quarterly, 2025-09-30) — Basic EPS: 2.26
CHRD cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 40487000.00
CHRD cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -340432000.00
CHRD cash_flow (quarterly, 2025-09-30) — Capital Expenditure Reported: -340432000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 151733000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Capital Stock: 675000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 629208000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 629208000.00
CHRD cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -74572000.00
CHRD cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 402355000.00
CHRD cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -372601000.00
CHRD cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 558967000.00
CHRD cash_flow (quarterly, 2025-09-30) — Change In Inventory: -6605000.00
CHRD cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -10022000.00
CHRD cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -36003000.00
CHRD cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -777000.00
CHRD cash_flow (quarterly, 2025-09-30) — Change In Receivables: 66922000.00
CHRD cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 13515000.00
CHRD cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 66922000.00
CHRD cash_flow (quarterly, 2025-09-30) — Changes In Cash: 588721000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Common Stock: 675000.00
CHRD cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -74572000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 8073941000.00
CHRD cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -83823000.00
CHRD income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 1117031000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 628698000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Current Assets: 2064152000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 145963000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 145963000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 2180000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 1527754000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Current Provisions: 16520000.00
CHRD cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 57649000.00
CHRD cash_flow (quarterly, 2025-09-30) — Deferred Tax: 57649000.00
CHRD cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 374919000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Derivative Product Liabilities: 1094000.00
CHRD income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 57157000.00
CHRD income_statement (quarterly, 2025-09-30) — Diluted EPS: 2.26
CHRD income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 129360000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Dividends Payable: 0.00
CHRD cash_flow (quarterly, 2025-09-30) — Dividends Received Cfi: 2396000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Duefrom Related Parties Current: 277359000.00
CHRD income_statement (quarterly, 2025-09-30) — EBIT: 189014000.00
CHRD income_statement (quarterly, 2025-09-30) — EBITDA: 563933000.00
CHRD income_statement (quarterly, 2025-09-30) — Earnings From Equity Interest: -4646000.00
CHRD cash_flow (quarterly, 2025-09-30) — Earnings Losses From Equity Investments: 4645000.00
CHRD cash_flow (quarterly, 2025-09-30) — End Cash Position: 629208000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Financial Assets: 4942000.00
CHRD cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 402355000.00
CHRD cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 218535000.00
CHRD cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: -20724000.00
CHRD income_statement (quarterly, 2025-09-30) — Gain On Sale Of Ppe: -365000.00
CHRD income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 20724000.00
CHRD income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 21861000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Goodwill: 0.00
CHRD balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 0.00
CHRD balance_sheet (quarterly, 2025-09-30) — Gross PPE: 14012244000.00
CHRD income_statement (quarterly, 2025-09-30) — Gross Profit: 195050000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Hedging Assets Current: 86200000.00
CHRD income_statement (quarterly, 2025-09-30) — Interest Expense: 18717000.00
CHRD income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 18717000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Interest Payable: 5177000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Inventory: 108498000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Invested Capital: 9552768000.00
CHRD cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -372601000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 124562000.00
CHRD cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 2002000000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 5770000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 1478827000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 1484597000.00
CHRD cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 2002000000.00
CHRD cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -1432528000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 124562000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 400382000.00
CHRD cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: 2571000.00
CHRD cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -83823000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Net Debt: 849619000.00
CHRD income_statement (quarterly, 2025-09-30) — Net Income: 130111000.00
CHRD income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 129360000.00
CHRD income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 130111000.00
CHRD income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 130111000.00
CHRD income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 130111000.00
CHRD cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 130111000.00
CHRD income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 130111000.00
CHRD income_statement (quarterly, 2025-09-30) — Net Interest Income: -18717000.00
CHRD cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 17864000.00
CHRD cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 569472000.00
CHRD cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 569472000.00
CHRD income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -18717000.00
CHRD cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -8745000.00
CHRD cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: -55000000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Net PPE: 10796402000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 8073941000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 1603141000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 1603141000.00
CHRD income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 543574000.00
CHRD income_statement (quarterly, 2025-09-30) — Normalized Income: 114556234.80
CHRD cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 558967000.00
CHRD cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -15714000.00
CHRD income_statement (quarterly, 2025-09-30) — Operating Income: 171155000.00
CHRD income_statement (quarterly, 2025-09-30) — Operating Revenue: 1312081000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 56865300.00
CHRD balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 2178000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 1792000.00
CHRD income_statement (quarterly, 2025-09-30) — Other Gand A: 21861000.00
CHRD income_statement (quarterly, 2025-09-30) — Other Income Expense: 17859000.00
CHRD cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: -7985000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 107256000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 6405000.00
CHRD income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 2146000.00
CHRD income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 2034000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Other Payable: 622172000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Other Properties: 77274000.00
CHRD income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 751000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Payables: 732601000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 1361299000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 27740000.00
CHRD income_statement (quarterly, 2025-09-30) — Pretax Income: 170297000.00
CHRD cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 23000.00
CHRD cash_flow (quarterly, 2025-09-30) — Purchase Of Business: -1243000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Raw Materials: 108498000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Receivables: 1210328000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Receivables Adjustments Allowances: -12639000.00
CHRD income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 1117031000.00
CHRD income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 374919000.00
CHRD cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -1432528000.00
CHRD cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -83823000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 2033764000.00
CHRD cash_flow (quarterly, 2025-09-30) — Sale Of Business: 3814000.00
CHRD income_statement (quarterly, 2025-09-30) — Selling General And Administration: 21861000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Share Issued: 67150747.00
CHRD income_statement (quarterly, 2025-09-30) — Special Income Charges: -365000.00
CHRD cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 6467000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 8073941000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 8073941000.00
CHRD income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 4804234.80
CHRD income_statement (quarterly, 2025-09-30) — Tax Provision: 40186000.00
CHRD income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.24
CHRD balance_sheet (quarterly, 2025-09-30) — Total Assets: 13097314000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 9552768000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Total Debt: 1630560000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 8073941000.00
CHRD income_statement (quarterly, 2025-09-30) — Total Expenses: 1140926000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 5023373000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 11033162000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 3495619000.00
CHRD income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 170790000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 48802000.00
CHRD income_statement (quarterly, 2025-09-30) — Total Unusual Items: 20359000.00
CHRD income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 20359000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 10285447.00
CHRD balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 1293994000.00
CHRD balance_sheet (quarterly, 2025-09-30) — Working Capital: 536398000.00
CHRD income_statement (annual, 2025-12-31) — +Operating Expense: 677706000.00
CHRD income_statement (quarterly, 2025-12-31) — +Operating Expense: 38971000.00
CHRD income_statement (annual, 2025-12-31) — +Total Revenue: 4877126000.00
CHRD income_statement (quarterly, 2025-12-31) — +Total Revenue: 1169439000.00
CHRD balance_sheet (annual, 2025-12-31) — Accounts Payable: 41795000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 41795000.00
CHRD balance_sheet (annual, 2025-12-31) — Accounts Receivable: 894309000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 894309000.00
CHRD balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -3572834000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -3572834000.00
CHRD balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 7339735000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 7339735000.00
CHRD cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 539324000.00
CHRD cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 1000.00
CHRD income_statement (annual, 2025-12-31) — Basic Average Shares: 57812000.00
CHRD income_statement (quarterly, 2025-12-31) — Basic Average Shares: 56839000.00
CHRD income_statement (annual, 2025-12-31) — Basic EPS: 0.74
CHRD income_statement (quarterly, 2025-12-31) — Basic EPS: 1.48
CHRD cash_flow (annual, 2025-12-31) — Beginning Cash Position: 36950000.00
CHRD cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 629208000.00
CHRD cash_flow (annual, 2025-12-31) — Capital Expenditure: -1347937000.00
CHRD cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -303117000.00
CHRD cash_flow (annual, 2025-12-31) — Capital Expenditure Reported: -1347937000.00
CHRD cash_flow (quarterly, 2025-12-31) — Capital Expenditure Reported: -303117000.00
CHRD balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 146480000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 146480000.00
CHRD balance_sheet (annual, 2025-12-31) — Capital Stock: 675000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Capital Stock: 675000.00
CHRD balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 189531000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 189531000.00
CHRD balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 189531000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 189531000.00
CHRD cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -317763000.00
CHRD cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -74345000.00
CHRD cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -82095000.00
CHRD cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -89066000.00
CHRD cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -1805981000.00
CHRD cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -755598000.00
CHRD cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 2040657000.00
CHRD cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 404987000.00
CHRD cash_flow (annual, 2025-12-31) — Change In Inventory: -16800000.00
CHRD cash_flow (quarterly, 2025-12-31) — Change In Inventory: -4457000.00
CHRD cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -4090000.00
CHRD cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 2621000.00
CHRD cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -165041000.00
CHRD cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -109007000.00
CHRD cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -3153000.00
CHRD cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -7839000.00
CHRD cash_flow (annual, 2025-12-31) — Change In Receivables: 181873000.00
CHRD cash_flow (quarterly, 2025-12-31) — Change In Receivables: 110472000.00
CHRD cash_flow (annual, 2025-12-31) — Change In Working Capital: -7211000.00
CHRD cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -8210000.00
CHRD cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 181873000.00
CHRD cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 110472000.00
CHRD cash_flow (annual, 2025-12-31) — Changes In Cash: 152581000.00
CHRD cash_flow (quarterly, 2025-12-31) — Changes In Cash: -439677000.00
CHRD balance_sheet (annual, 2025-12-31) — Common Stock: 675000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Common Stock: 675000.00
CHRD cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -317763000.00
CHRD cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -74345000.00
CHRD balance_sheet (annual, 2025-12-31) — Common Stock Equity: 8079954000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 8079954000.00
CHRD cash_flow (annual, 2025-12-31) — Common Stock Payments: -364877000.00
CHRD cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -7040000.00
CHRD income_statement (annual, 2025-12-31) — Cost Of Revenue: 4010706000.00
CHRD income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 1042694000.00
CHRD balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 592698000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 592698000.00
CHRD balance_sheet (annual, 2025-12-31) — Current Assets: 1538069000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Current Assets: 1538069000.00
CHRD balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 135962000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 135962000.00
CHRD balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 135962000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 135962000.00
CHRD balance_sheet (annual, 2025-12-31) — Current Liabilities: 1450587000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 1450587000.00
CHRD balance_sheet (annual, 2025-12-31) — Current Provisions: 49117000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Current Provisions: 49117000.00
CHRD cash_flow (annual, 2025-12-31) — Deferred Income Tax: 119407000.00
CHRD cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 12708000.00
CHRD cash_flow (annual, 2025-12-31) — Deferred Tax: 119407000.00
CHRD cash_flow (quarterly, 2025-12-31) — Deferred Tax: 12708000.00
CHRD cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 1470171000.00
CHRD cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 368446000.00
CHRD balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 0.00
CHRD balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 0.00
CHRD income_statement (annual, 2025-12-31) — Diluted Average Shares: 57852000.00
CHRD income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 56839000.00
CHRD income_statement (annual, 2025-12-31) — Diluted EPS: 0.74
CHRD income_statement (quarterly, 2025-12-31) — Diluted EPS: 1.48
CHRD income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 42723000.00
CHRD income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 83993000.00
CHRD balance_sheet (annual, 2025-12-31) — Dividends Payable: 859000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Dividends Payable: 859000.00
CHRD cash_flow (annual, 2025-12-31) — Dividends Received Cfi: 11595000.00
CHRD cash_flow (quarterly, 2025-12-31) — Dividends Received Cfi: 2413000.00
CHRD balance_sheet (annual, 2025-12-31) — Duefrom Related Parties Current: 233919000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Duefrom Related Parties Current: 233919000.00
CHRD income_statement (annual, 2025-12-31) — EBIT: 323634000.00
CHRD income_statement (quarterly, 2025-12-31) — EBIT: 142701000.00
CHRD income_statement (annual, 2025-12-31) — EBITDA: 1793805000.00
CHRD income_statement (quarterly, 2025-12-31) — EBITDA: 511147000.00
CHRD income_statement (annual, 2025-12-31) — Earnings From Equity Interest: -12957000.00
CHRD income_statement (quarterly, 2025-12-31) — Earnings From Equity Interest: -2450000.00
CHRD cash_flow (annual, 2025-12-31) — End Cash Position: 189531000.00
CHRD cash_flow (quarterly, 2025-12-31) — End Cash Position: 189531000.00
CHRD balance_sheet (annual, 2025-12-31) — Financial Assets: 8366000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Financial Assets: 8366000.00
CHRD cash_flow (annual, 2025-12-31) — Financing Cash Flow: -82095000.00
CHRD cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -89066000.00
CHRD cash_flow (annual, 2025-12-31) — Free Cash Flow: 692720000.00
CHRD cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 101870000.00
CHRD cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -114661000.00
CHRD cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -31987000.00
CHRD income_statement (annual, 2025-12-31) — Gain On Sale Of Ppe: 8711000.00
CHRD income_statement (quarterly, 2025-12-31) — Gain On Sale Of Ppe: 4083000.00
CHRD income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 127618000.00
CHRD income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 44944000.00
CHRD income_statement (annual, 2025-12-31) — General And Administrative Expense: 126294000.00
CHRD income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 33516000.00
CHRD balance_sheet (annual, 2025-12-31) — Goodwill: 0.00
CHRD balance_sheet (quarterly, 2025-12-31) — Goodwill: 0.00
CHRD balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 0.00
CHRD balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 0.00
CHRD balance_sheet (annual, 2025-12-31) — Gross PPE: 14922112000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Gross PPE: 14922112000.00
CHRD income_statement (annual, 2025-12-31) — Gross Profit: 866420000.00
CHRD income_statement (quarterly, 2025-12-31) — Gross Profit: 126745000.00
CHRD balance_sheet (annual, 2025-12-31) — Hedging Assets Current: 77312000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Hedging Assets Current: 77312000.00
CHRD income_statement (annual, 2025-12-31) — Interest Expense: 80150000.00
CHRD income_statement (quarterly, 2025-12-31) — Interest Expense: 26826000.00
CHRD income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 80150000.00
CHRD income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 26826000.00
CHRD cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 51698000.00
CHRD balance_sheet (annual, 2025-12-31) — Interest Payable: 28594000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Interest Payable: 28594000.00
CHRD balance_sheet (annual, 2025-12-31) — Inventory: 115713000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Inventory: 115713000.00
CHRD balance_sheet (annual, 2025-12-31) — Invested Capital: 9559535000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Invested Capital: 9559535000.00
CHRD cash_flow (annual, 2025-12-31) — Investing Cash Flow: -1805981000.00
CHRD cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -755598000.00
CHRD balance_sheet (annual, 2025-12-31) — Investments And Advances: 119698000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 119698000.00
CHRD cash_flow (annual, 2025-12-31) — Issuance Of Debt: 5326000000.00
CHRD cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 139000000.00
CHRD balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 10518000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 10518000.00
CHRD balance_sheet (annual, 2025-12-31) — Long Term Debt: 1479581000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 1479581000.00
CHRD balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 1490099000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 1490099000.00
CHRD cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 5326000000.00
CHRD cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 139000000.00
CHRD cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -4674349000.00
CHRD cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -139533000.00
CHRD balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 119698000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 119698000.00
CHRD balance_sheet (annual, 2025-12-31) — Long Term Provisions: 432802000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 432802000.00
CHRD cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -550906000.00
CHRD cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: -534207000.00
CHRD cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -364877000.00
CHRD cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -7040000.00
CHRD balance_sheet (annual, 2025-12-31) — Net Debt: 1290050000.00
CHRD balance_sheet (quarterly, 2025-12-31) — Net Debt: 1290050000.00
CHRD income_statement (annual, 2025-12-31) — Net Income: 44459000.00
CHRD income_statement (quarterly, 2025-12-31) — Net Income: 84416000.00
CHRD income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 42723000.00
CHRD income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 83993000.00
CHRD income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 44459000.00
CHRD income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 84416000.00
CHRD income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 44459000.00
CHRD income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 84416000.00
CHRD income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 44459000.00
CHRD income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 84416000.00
CHRD cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 44459000.00
CHRD cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 84416000.00
CHRD income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 44459000.00
CHRD income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 84416000.00
CHRD income_statement (annual, 2025-12-31) — Net Interest Income: -80150000.00
CHRD income_statement (quarterly, 2025-12-31) — Net Interest Income: -26826000.00
CHRD cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 56267000.00
CHRD cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 24313000.00
CHRD cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 651651000.00
CHRD cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -533000.00
CHRD cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 651651000.00